Drugs in the COVID-19 pandemic: Analysis of the commercialization of azithromycin, hydroxychloroquine, ivermectin and nitazoxanide in Brazil. Research, Society and Development, [S. l.], v. 11, n. 6, p. e16711628726, 2022. DOI: 10.33448/rsd-v11i6.28726. Disponível em: https://rsdjournal.org/rsd/article/view/28726. Acesso em: 5 dec. 2025.